Skip to Main content Skip to Navigation
Journal articles

Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling

Abstract : We read with great interest the paper of Giannelou et al1 reporting, for the first time, the efficacy of tumour necrosis factor (TNF) inhibitors in sideroblastic anaemia with immunodeficiency, fevers and developmental delay (SIFD). These authors also demonstrated high levels of interleukin (IL)-6, IL-12p40, IL-18, interferon (IFN)-γ and IFN-induced chemokines (IP-10 and MIG) in two patients. Herein, we wish to highlight that an activation of the type I IFN pathway may also be observed in SIFD [...]
Document type :
Journal articles
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-01819255
Contributor : Marie-Christine Vougny <>
Submitted on : Wednesday, June 20, 2018 - 10:58:38 AM
Last modification on : Wednesday, August 19, 2020 - 11:17:43 AM

File

annrheumdis-2018-213745.full.p...
Files produced by the author(s)

Licence


Copyright

Identifiers

Citation

Marie-Louise Frémond, Isabelle Melki, Sven Kracker, Vincent Bondet, Darragh Duffy, et al.. Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, ⟨10.1136/annrheumdis-2018-213745⟩. ⟨pasteur-01819255⟩

Share

Metrics

Record views

307

Files downloads

762